BB MEDTECH sells 1.32 mn shares to Deutsche Bank

5/15/2007, 7:15 PM (Source: GlobeNewswire)
Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------



As announced on May 14, 2007, BB MEDTECH AG has sold through its
wholly-owned subsidiary MEDHEALTH N.V., 1.32 mn treasury shares to
Deutsche Bank, London, as underlying for the emitted mandatory
exchangeable bond. The gross sales price is CHF 80.1821 and is
calculated at the average of the volume weighted average prices of
the shares from May 14 and May 15, 2007. The issue size of the
transaction is CHF 105 mn, with a coupon of 3.25% p.a. The issue date
will be on May 18, 2007 with a maturity date of May 18, 2012.

0.228 mn of these shares were previously bought back under the share
buy-back program initiated on August 8, 2006. Through the sale of
treasury shares, MEDHEALTH N.V. builds up a short position of 0.3 mn
shares which may later be covered by a capital increase, particularly
if shares of BB MEDTECH trade at a premium to their NAV (Net Asset
Value). Shares may also be purchased by MEDHEALTH N.V. in the open
market.

The admission of the bond will be made to the Euro MTF Market of the
Luxembourg Stock Exchange (ISIN XS 0301569199).

For further information please contact:
Bellevue Asset Management AG, Seestrasse 16, 8700 Küsnacht,
Switzerland
Anja Stubenrauch or Dr. Christian Lach, Tel. +41 44 267 67 00



--- End of Message ---

BB MEDTECH AG
Vordergasse 3 Schaffhausen Switzerland

WKN: 898194;
ISIN: CH0000428661; Index: IGSP;
Listed: Investment Companies in SWX Swiss Exchange;
Copyright GlobeNewswire, Inc. 2016. All rights reserved.
You can register yourself on the website to receive press releases directly via e-mail to your own e-mail account.